Neurology

>

Latest News

FDA expands diazepam nasal spray for seizure clusters to ages 2–5 | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA expands diazepam nasal spray for seizure clusters to ages 2–5

April 16th 2025

Diazepam nasal spray (Valtoco) is approved for short-term treatment of seizure clusters, now in patients aged 2 years and older.

Preterm skin-to-skin contact does not improve neurodevelopment at 2–3 years | Image Credit: © Colin - © Colin - stock.adobe.com.
Preterm skin-to-skin contact does not improve neurodevelopment at 2–3 years

April 16th 2025

Preterm birth associated with long-term cognitive issues in children | Image Credit: © Rattanachat - © Rattanachat - stock.adobe.com.
Preterm birth associated with long-term cognitive issues in children

April 14th 2025

FDA accepts sBLA to expand fremanezumab-vfrm indication | Image Credit: © Araki Illustrations - © Araki Illustrations  - stock.adobe.com.
FDA accepts sBLA to expand fremanezumab-vfrm indication for episodic migraines in children

April 7th 2025

Navepegritide NDA submitted to treat children with achondroplasiaLatest revision | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
Navepegritide NDA submitted to treat children with achondroplasia

March 31st 2025

More News

© 2025 MJH Life Sciences

All rights reserved.